Novo Nordisk, AWS Partner to Accelerate Drug Discovery Through AI
Novo Nordisk and AWS have created a co-innovation hub in London, where engineers and scientists from both companies work together to accelerate drug discovery and development.
E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com
Novo Nordisk and AWS have created a co-innovation hub in London, where engineers and scientists from both companies work together to accelerate drug discovery and development.
The global AI in healthcare market is projected to grow from USD 20.2 billion in 2025 to USD 146.3 billion by 2031, according to a new report by Wissen Research.
HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.

